Why is hypertension so frequently uncontrolled in secondary prevention?
- PMID: 12777958
- DOI: 10.1097/00004872-200306000-00021
Why is hypertension so frequently uncontrolled in secondary prevention?
Abstract
Objective: To analyze blood pressure (BP) control in secondary prevention.
Design: Individual data of two cross-sectional studies on preventive cardiology (PRATIK and ESPOIR studies conducted, respectively, in general practice and with private cardiologists) were analyzed.
Setting: Primary care.
Participants: Patients both with treated hypertension and coronary disease.
Main outcome measures: Risk factors, treatments, cardiovascular history and BP were recorded. Each population was divided in three groups: group I, no other risk factor; group II, one or two risk factors; group III, three or more risk factors or diabetes.
Results: A total of 1423 and 2596 patients, respectively, recruited in general practice and by cardiologists were analyzed. Of these, 473 (33.24%) and 1060 (40.83%) patients, respectively, had controlled hypertension. Among uncontrolled hypertensives, more than 50% had borderline isolated systolic hypertension. Associated risk factors negatively affect hypertension control, which had been achieved in a lower percentage of patients in group III than in group I (general practice, 26.28 versus 42.20%; cardiological practice, 32.42 versus 56.13%). In general practice, the percentage of patients receiving beta-blockers was significantly lower in group III. Among individuals with uncontrolled hypertension, only 17.58 and 26.69% received at least three-drug treatment including diuretics in general and in cardiological practice, respectively.
Conclusion: The negative influence of associated risk factors and the under-use of combination therapy contribute to poor BP control. In addition the high frequency of borderline isolated systolic hypertension suggests that the prerequisite to improve hypertension control should be to convince practitioners of the beneficial effect of tight systolic BP control (below 140 mmHg) in secondary prevention.
Similar articles
-
[Hypertension management in patients with stable coronary disease].Arch Mal Coeur Vaiss. 2002 Jul-Aug;95(7-8):657-60. Arch Mal Coeur Vaiss. 2002. PMID: 12365075 French.
-
Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK study).J Hypertens. 2002 Apr;20(4):779-84. doi: 10.1097/00004872-200204000-00038. J Hypertens. 2002. PMID: 11910316
-
Association between blood pressure, the treatment of hypertension, and cardiovascular risk factors in women.J Hypertens. 2000 Jul;18(7):833-41. doi: 10.1097/00004872-200018070-00003. J Hypertens. 2000. PMID: 10930179
-
Treatment of Hypertension: Which Goal for Which Patient?Adv Exp Med Biol. 2017;956:117-127. doi: 10.1007/5584_2016_97. Adv Exp Med Biol. 2017. PMID: 27722961 Review.
-
The Role of Beta-Blockers in the Treatment of Hypertension.Adv Exp Med Biol. 2017;956:149-166. doi: 10.1007/5584_2016_36. Adv Exp Med Biol. 2017. PMID: 27957711 Review.
Cited by
-
Treatment strategies for resistant arterial hypertension.Dtsch Arztebl Int. 2011 Oct;108(43):725-31. doi: 10.3238/arztebl.2011.0725. Epub 2011 Oct 28. Dtsch Arztebl Int. 2011. PMID: 22114648 Free PMC article. Review.
-
Relationship between blood pressure measurements recorded on patients' charts in family physicians' offices and subsequent 24 hour ambulatory blood pressure monitoring.BMC Cardiovasc Disord. 2004 Mar 29;4:2. doi: 10.1186/1471-2261-4-2. BMC Cardiovasc Disord. 2004. PMID: 15050033 Free PMC article.
-
Assessment of drug-related problems and their impact on blood pressure control in patients with hypertension.Eur J Hosp Pharm. 2016 May;23(3):126-130. doi: 10.1136/ejhpharm-2015-000712. Epub 2015 Oct 16. Eur J Hosp Pharm. 2016. PMID: 31156832 Free PMC article.
-
Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) guidelines for the management of arterial hypertension.Vasc Health Risk Manag. 2007;3(6):783-95. Vasc Health Risk Manag. 2007. PMID: 18200799 Free PMC article. Review. No abstract available.
-
The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.J Clin Hypertens (Greenwich). 2005 Oct;7(10):578-86. doi: 10.1111/j.1524-6175.2004.04720.x. J Clin Hypertens (Greenwich). 2005. PMID: 16227760 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical